Cat.#: ACPP-1316
| Despition | GPCR GPR7 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1694 | Mouse FGF 1 Protein, His (AC1694) | 5 µg | inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
| ACPP-1560 | Human RBM17 Protein (AC1560) | 2 µg | inquiry |
| ACPP-1812 | Human IMPA1 Protein (AC1812) | 5 µg | inquiry |
| ACPP-1319 | Axin 2 Blocking Peptide (AC1319) | 250 µg | inquiry |
| ACPP-1708 | Human PRNP Protein (AC1708) | 2 µg | inquiry |
| ACPP-1410 | Human MEOX2 Protein (AC1410) | 2 µg | inquiry |
| ACPP-1243 | ELOVL4 Blocking Peptide (AC1243) | 250 µg | inquiry |
| ACPP-1456 | Human HEXA Protein (AC1456) | 5 µg | inquiry |
| ACPP-1501 | Human STX2 Protein (AC1501) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.